Sign up for our Oncology Central weekly news round-up

The role of liquid biopsies in breast cancer: a peek behind the paper with Kevin Koo

Written by Kevin Koo (XING Technologies, Brisbane, Australia)

We recently spoke with Kevin Koo, PhD (Lead Assay Development Scientist, XING Technologies, Brisbane, Australia). Koo is also an Honorary Fellow of the University of Queensland Centre for Clinical Research. His work focuses on the multidisciplinary areas of molecular diagnostics development, translation and commercialization for precision oncology applications. In this peek behind the paper, Koo gives an insight into his recent article published in Breast Cancer Management, discussing the use of liquid biopsies in breast cancer.What began your interest in researching liquid biopsies for breast cancer? I started off in the liquid biopsy research area with the detection of urinary...

To view this content, please register now for access

It's completely free